Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 C1-inhibitors 1.4.3 Kallikrein Inhibitor (Kalbitor) 1.5 Market by Application 1.5.1 Global Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacies 1.5.3 Independent Pharmacies and Outlets 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Plasma Protease C1-inhibitor Treatment Market Size 2.2 Plasma Protease C1-inhibitor Treatment Growth Trends by Regions 2.2.1 Plasma Protease C1-inhibitor Treatment Market Size by Regions (2014-2025) 2.2.2 Plasma Protease C1-inhibitor Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Plasma Protease C1-inhibitor Treatment Market Size by Manufacturers 3.1.1 Global Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served 3.3 Key Players Plasma Protease C1-inhibitor Treatment Product/Solution/Service 3.4 Date of Enter into Plasma Protease C1-inhibitor Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) 4.2 Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Plasma Protease C1-inhibitor Treatment Market Size (2014-2019) 5.2 Plasma Protease C1-inhibitor Treatment Key Players in United States 5.3 United States Plasma Protease C1-inhibitor Treatment Market Size by Type 5.4 United States Plasma Protease C1-inhibitor Treatment Market Size by Application 6 Europe 6.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2014-2019) 6.2 Plasma Protease C1-inhibitor Treatment Key Players in Europe 6.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type 6.4 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application 7 China 7.1 China Plasma Protease C1-inhibitor Treatment Market Size (2014-2019) 7.2 Plasma Protease C1-inhibitor Treatment Key Players in China 7.3 China Plasma Protease C1-inhibitor Treatment Market Size by Type 7.4 China Plasma Protease C1-inhibitor Treatment Market Size by Application 8 Japan 8.1 Japan Plasma Protease C1-inhibitor Treatment Market Size (2014-2019) 8.2 Plasma Protease C1-inhibitor Treatment Key Players in Japan 8.3 Japan Plasma Protease C1-inhibitor Treatment Market Size by Type 8.4 Japan Plasma Protease C1-inhibitor Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size (2014-2019) 9.2 Plasma Protease C1-inhibitor Treatment Key Players in Southeast Asia 9.3 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Type 9.4 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Application 10 India 10.1 India Plasma Protease C1-inhibitor Treatment Market Size (2014-2019) 10.2 Plasma Protease C1-inhibitor Treatment Key Players in India 10.3 India Plasma Protease C1-inhibitor Treatment Market Size by Type 10.4 India Plasma Protease C1-inhibitor Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Plasma Protease C1-inhibitor Treatment Market Size (2014-2019) 11.2 Plasma Protease C1-inhibitor Treatment Key Players in Central & South America 11.3 Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Type 11.4 Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Application 12 International Players Profiles 12.1 Shire plc 12.1.1 Shire plc Company Details 12.1.2 Company Description and Business Overview 12.1.3 Plasma Protease C1-inhibitor Treatment Introduction 12.1.4 Shire plc Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019) 12.1.5 Shire plc Recent Development 12.2 CSL Limited 12.2.1 CSL Limited Company Details 12.2.2 Company Description and Business Overview 12.2.3 Plasma Protease C1-inhibitor Treatment Introduction 12.2.4 CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019) 12.2.5 CSL Limited Recent Development 12.3 Sanquin 12.3.1 Sanquin Company Details 12.3.2 Company Description and Business Overview 12.3.3 Plasma Protease C1-inhibitor Treatment Introduction 12.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019) 12.3.5 Sanquin Recent Development 12.4 Pharming Group N.V. 12.4.1 Pharming Group N.V. Company Details 12.4.2 Company Description and Business Overview 12.4.3 Plasma Protease C1-inhibitor Treatment Introduction 12.4.4 Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019) 12.4.5 Pharming Group N.V. Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Plasma Protease C1-inhibitor Treatment Key Market Segments Table Key Players Plasma Protease C1-inhibitor Treatment Covered Table Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type 2014-2025 Figure C1-inhibitors Figures Table Key Players of C1-inhibitors Figure Kallikrein Inhibitor (Kalbitor) Figures Table Key Players of Kallikrein Inhibitor (Kalbitor) Table Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacies Case Studies Figure Independent Pharmacies and Outlets Case Studies Figure Plasma Protease C1-inhibitor Treatment Report Years Considered Table Global Plasma Protease C1-inhibitor Treatment Market Size 2014-2025 (Million US$) Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Plasma Protease C1-inhibitor Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Plasma Protease C1-inhibitor Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Plasma Protease C1-inhibitor Treatment Market Share by Regions 2014-2019 Figure Global Plasma Protease C1-inhibitor Treatment Market Share by Regions 2014-2019 Figure Global Plasma Protease C1-inhibitor Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Plasma Protease C1-inhibitor Treatment Market Share by Manufacturers (2014-2019) Figure Global Plasma Protease C1-inhibitor Treatment Market Share by Manufacturers in 2018 Table Global Plasma Protease C1-inhibitor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Plasma Protease C1-inhibitor Treatment Product/Solution/Service Table Date of Enter into Plasma Protease C1-inhibitor Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$) Table Global Plasma Protease C1-inhibitor Treatment Market Size Share by Type (2014-2019) Figure Global Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2014-2019) Table Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table Global Plasma Protease C1-inhibitor Treatment Market Size Share by Application (2014-2019) Figure Global Plasma Protease C1-inhibitor Treatment Market Size Market Share by Application (2014-2019) Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application in 2018 Figure United States Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019) Table United States Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$) Table United States Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019) Table United States Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table United States Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019) Figure Europe Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019) Table Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019) Table Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019) Figure China Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$) Table China Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$) Table China Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019) Table China Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-20189) (Million US$) Table China Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019) Table China Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table China Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019) Figure Japan Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019) Table Japan Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019) Table Japan Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019) Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019) Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019) Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019) Figure India Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$) Table India Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$) Table India Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019) Table India Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$) Table India Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019) Table India Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table India Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019) Figure Central & South America Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019) Table Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019) Table Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019) Table Shire plc Company Details Table Shire plc Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019) (Million US$) Figure Shire plc Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019) Table Shire plc Recent Development Table CSL Limited Company Details Table CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)(Million US$) Figure CSL Limited Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019) Table CSL Limited Recent Development Table Sanquin Company Details Table Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)(Million US$) Figure Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019) Table Sanquin Recent Development Table Pharming Group N.V. Company Details Table Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)(Million US$) Figure Pharming Group N.V. Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019) Table Pharming Group N.V. Recent Development Table Global Plasma Protease C1-inhibitor Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Plasma Protease C1-inhibitor Treatment Market Size Share by Regions (2019-2025) Figure Global Plasma Protease C1-inhibitor Treatment Market Size Share by Regions in 2025 Figure United States Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Plasma Protease C1-inhibitor Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Product (2019-2025) Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Product in 2025 Table Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2019-2025) Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Shire plc CSL Limited Sanquin Pharming Group N.V.